Professor, Clinical Oncology

Staff Profile: Professor Ann Henry | School of Medicine | University of Leeds

I am a Professor in Clinical Oncology at the University of Leeds and Honorary Consultant Clinical Oncologist at Leeds Teaching Hospitals NHS Trust. I specialise in the radiation treatment of urological cancers. My research optimises radiation treatments to improve overall survival and reduce treatment related side effects.

My research interests are personalised radiotherapy delivery, radiotherapy clinical trials and patient reported outcomes. My technical radiotherapy research areas are optimising treatment delivery for pelvic cancers by incorporating MR imaging, using Intensity Modulated Radiotherapy (IMRT) and Image Guided Radiotherapy (IGRT) and delivering image guided brachytherapy (IGBT). I am the lead for training our future leaders in cancer treatment and radiotherapy research.

Professor of Clinical Oncology

Staff Profile: Professor David Sebag-Montefiore | School of Medicine | University of Leeds

I am an academic clinical oncologist at the University of Leeds and an honorary Clinical Oncologist at Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust. I lead the Leeds Radiotherapy Research Group, located in the Leeds Institute of Medicine at St James’s University Hospital and I am a Clinical Director of the Leeds Clinical Trial Research Unit.

I have an extensive portfolio of practice-changing innovative clinical trials focussing on gastrointestinal cancer with a focus on rectal and anal cancer.

My research interests include :

• the personalisation of radiotherapy for primary and recurrent lower gastrointestinal cancers;
• integration of translational research questions into clinical trials and developing designs that use biomarkers to stratify or determine novel treatment
• achieving greater scientific depth of the analysis of clinical trials including impact and precision radiotherapy – to optimise the technical and patient focused delivery of radiotherapy for primary and recurrent rectal and anal cancer. This includes use of Patient Reported Outcomes in clinical trial and non-trial patients.

I am also a determined advocate for the development of our future leaders in radiotherapy research.

Nick supports the directors of RadNet with general day-to-day administration of RadNet Leeds and coordinates RadNet Leeds’ activities.

Nick can be contacted on N.Preston@leeds.ac.uk